Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;27(7):2131-2162.
doi: 10.1007/s10461-022-03948-3. Epub 2022 Dec 20.

Substance Use and Adherence to HIV Pre-Exposure Prophylaxis in Studies Enrolling Men Who Have Sex with Men and Transgender Women: A Systematic Review

Affiliations
Review

Substance Use and Adherence to HIV Pre-Exposure Prophylaxis in Studies Enrolling Men Who Have Sex with Men and Transgender Women: A Systematic Review

Nioud Mulugeta Gebru et al. AIDS Behav. 2023 Jul.

Abstract

Optimal adherence to pre-exposure prophylaxis (PrEP) is critical, but challenging. Men who have sex with men and transgender women have high rates of HIV incidence and substance use. Substance use is associated with reduced adherence to other medications, but associations between substance use and adherence to PrEP are less clear. Thus, the current review 1) systematically evaluates the measurement of substance use and PrEP adherence in studies examining both and 2) summarizes reported findings. Peer-reviewed articles published between 2010 - April 2021 examining associations between substance use and PrEP adherence were reviewed. Fifty studies met inclusion criteria. Assessment of substance use (i.e., mostly via self-reports at baseline) and PrEP adherence (i.e., often via tenofovir diphosphate [TFV-DP] concentration levels at follow-up) varied considerably across studies. Many studies used categorical variables (e.g., substance use: yes/no). Studies using TFV-DP levels defined adherence consistently (i.e., TFV-DP ≥ 700 fmol/punch), with slight variations. Qualitative studies (n = 10) indicated that substance use (mainly alcohol) is related to poorer PrEP adherence. While quantitative findings to date are equivocal for alcohol, there is a pattern of findings linking stimulant use with poorer PrEP adherence. This review reveals four methodological gaps, which can be addressed in future research by: 1) use of uniform benchmarks for substance use measures, 2) prospective assessment for substance use, 3) use of continuous outcome variables wherever possible, and 4) more extensive consideration of potential confounders. Addressing these methodological gaps may help us reach more definitive conclusions regarding associations between substance use and PrEP adherence.

Keywords: PrEP adherence; alcohol use; medication adherence; non-stimulant use; stimulant use.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest All authors report no conflicts of interest.

Figures

Fig. 1
Fig. 1
PRISMA diagram showing identification, screening, eligibility, and inclusion of studies

Similar articles

Cited by

References

    1. CDC. PrEP | HIV Basics | HIV/AIDS | CDC [Internet]. 2020. [cited 2020 Jun 30]. Available from: https://www.cdc.gov/hiv/basics/prep.html.
    1. CDC. HIV Basics | HIV/AIDS | CDC [Internet]. 2020. [cited 2020 Jun 30]. Available from: https://www.cdc.gov/hiv/basics/index.html.
    1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men who have sex with men. N Engl J Med. 2010. Dec;30(27):2587–99. 363(. - PMC - PubMed
    1. Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017. Sep 1;4(9):e402–10. - PubMed
    1. Finlayson T. Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men — 20 Urban Areas, 2014 and 2017. MMWR Morb Mortal Wkly Rep [Internet]. 2019. [cited 2020 Jun 30];68. Available from: https://www.cdc.gov/mmwr/volumes/68/wr/mm6827a1.htm. - PMC - PubMed